These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7046844)

  • 1. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations.
    Lichtman MA; Rowe JM
    Blood; 1982 Aug; 60(2):279-83. PubMed ID: 7046844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Managing the problem of hyperleukocytosis in acute leukemia.
    Ablin AR
    Am J Pediatr Hematol Oncol; 1984; 6(3):287-90. PubMed ID: 6393793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial treatment of acute childhood leukemia with extreme leukocytosis by blood exchange transfusion -- rheological aspects (author's transl)].
    Klose HJ; Kelson S; Schwarzbach K; Janka G; Netzel B; Haas R; Betke K
    Klin Padiatr; 1981 May; 193(3):172-6. PubMed ID: 7265789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
    Aqui N; O'Doherty U
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter study.
    Zhang X; Tu Y; Shen J; Feng Y; Ma H; Bai L; Li X; Lin Z; Dai L; Gong F; Lu T; Zhou J; Chen H; Lv Q; Zhu Z; Ruan C
    Leuk Lymphoma; 2022 Nov; 63(11):2636-2644. PubMed ID: 35731036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary?
    Nelson SC; Bruggers CS; Kurtzberg J; Friedman HS
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):351-5. PubMed ID: 8392304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy.
    Basade M; Dhar AK; Kulkarni SS; Sastry PS; Yadav RP; Parikh BS; Pai SK; Nair CN; Kurkure PA; Advani SH
    Med Pediatr Oncol; 1995 Sep; 25(3):204-7. PubMed ID: 7623730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microrheological aspects in extreme leukocytotic acute childhood leukemia.
    Klose HJ; Kelson S; Janka G; Schwarzbach K; Haas R; Betke K
    Bibl Haematol; 1981; (47):258-63. PubMed ID: 6950721
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute hyperleukocytic lymphoblastic leukemia (greater than or equal to 100,000 leukocytes/mm3). Metabolic changes during induction treatment. Study, prevention and treatment].
    Leverger G; Tourani JM; Beuzeboc P; Schaison G
    Arch Fr Pediatr; 1985 Apr; 42(4):295-9. PubMed ID: 3859253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis.
    Eguiguren JM; Schell MJ; Crist WM; Kunkel K; Rivera GK
    Blood; 1992 Feb; 79(4):871-5. PubMed ID: 1737097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2 cases of excessively hyperleukocytic acute leukemia in infants (1,800,000 leukocytes)].
    Bernard J; Bussel A; Sée G; Schaison G; Dresch C; Chavelet F; Jacquillat C
    Nouv Rev Fr Hematol; 1968; 8(6):847-9. PubMed ID: 4236867
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukopheresis for profound hyperleukocytosis.
    Chekol SS; Bhatnagar B; Gojo I; Hess JR
    Transfus Apher Sci; 2012 Feb; 46(1):29-31. PubMed ID: 22082657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodilution.
    Messmer K; Sunder-Plassmann L
    Prog Surg; 1974; 13():208-45. PubMed ID: 4614329
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early complications and treatment of marked blastic hyperleukocytosis in children with leukemia].
    Kubiczek K; Rytlewska M
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):889-91. PubMed ID: 2487945
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children.
    Bunin NJ; Kunkel K; Callihan TR
    Med Pediatr Oncol; 1987; 15(5):232-5. PubMed ID: 3477680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exchange transfusion as a treatment for hyperleukocytosis, anemia, and metabolic abnormalities in patients with leukemia.
    Shende A; Festa R; Honigman R; Lanzkowsky P
    J Pediatr; 1981 May; 98(5):851-2. PubMed ID: 7229777
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of Hyperleukocytosis.
    Ruggiero A; Rizzo D; Amato M; Riccardi R
    Curr Treat Options Oncol; 2016 Feb; 17(2):7. PubMed ID: 26820286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations.
    Lichtman MA
    J Clin Invest; 1973 Feb; 52(2):350-8. PubMed ID: 4509637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of leukemic hyperleukocytosis with only fluid and allopurinol therapy.
    Lascari AD
    Am J Dis Child; 1991 Sep; 145(9):969-70. PubMed ID: 1877573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.